New antibiotic trial aims to tame Kids' belly infections

NCT ID NCT06794541

Recruiting now Disease control Sponsor: Tetraphase Pharmaceuticals, Inc Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 22 times

Summary

This study tests a new antibiotic called eravacycline in children aged 8 to 17 who have serious abdominal infections. The main goal is to see if the drug is safe and how the body processes it. About 35 children will take part, receiving the medicine through an IV.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Ann and Robert H Lurie Children's Hospital of Chicago
RECRUITING

Chicago, Illinois, 60611, United States
Children's Hospital of LSU Health Sciences Center Shreveport
RECRUITING

Shreveport, Louisiana, 71101, United States
Children's Hospital of Orange County
RECRUITING

Orange, California, 92868, United States
UCLA Ronald Reagan University of California Los Angeles Medical Center
RECRUITING

Los Angeles, California, 90095, United States
West Virginia University Medicine Children's Hospital
RECRUITING

Morgantown, West Virginia, 26506, United States

Conditions

Explore the condition pages connected to this study.

COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAI)